Mj Cuadrado

Summary

Publications

  1. ncbi request reprint Headache and systemic lupus erythematosus
    M J Cuadrado
    Lupus Research Unit, The Rayne Institute, St Thomas Hospital, London, UK
    Lupus 12:943-6. 2003
  2. doi request reprint Proteomics in antiphospholipid syndrome: a review
    M J Cuadrado
    Lupus Research Unit, St Thomas Hospital, London, UK
    Lupus 19:385-8. 2010
  3. ncbi request reprint Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS)
    Maria J Cuadrado
    Lupus Research Unit, Rayne Institute, St Thomas Hospital, London SE1 7EH, UK
    Rheumatology (Oxford) 53:275-84. 2014
  4. doi request reprint Is it time for biosimilars in autoimmune diseases?
    Maria Jose Cuadrado
    Louise Coote Lupus Unit, Guy s and St Thomas NHS Foundation Trust, St Thomas Hospital, London, UK
    Autoimmun Rev 12:954-7. 2013
  5. ncbi request reprint Thalidomide for the treatment of resistant cutaneous lupus: efficacy and safety of different therapeutic regimens
    Maria J Cuadrado
    Lupus Research Unit, The Rayne Institute, St Thomas Hospital, London, United Kingdom
    Am J Med 118:246-50. 2005
  6. ncbi request reprint Antiphospholipid syndrome
    M J Cuadrado
    Lupus Research Unit, The Rayne Institute, St Thomas Hospital, Lambeth Palace Road, SE1 7EH, London, UK
    Clin Exp Med 3:129-39. 2003
  7. ncbi request reprint Treatment and monitoring of patients with antiphospholipid antibodies and thrombotic history (Hughes syndrome)
    Maria J Cuadrado
    St Thomas Hospital, Lupus Research Unit, London SE1 7EH, United Kingdom
    Curr Rheumatol Rep 4:392-8. 2002
  8. ncbi request reprint Hughes (antiphospholipid) syndrome. Clinical features
    M J Cuadrado
    Lupus Research Unit, Rayne Institute, St. Thomas' Hospital, London, United Kingdom
    Rheum Dis Clin North Am 27:507-24, v. 2001
  9. pmc Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis
    P Alba
    Lupus Research Unit, The Rayne Institute, UK
    Ann Rheum Dis 62:556-60. 2003
  10. pmc Characteristics of patients with antiphospholipid syndrome with major bleeding after oral anticoagulant treatment
    G Castellino
    Lupus Research Unit, The Rayne Institute, St Thomas's Hospital, London, UK
    Ann Rheum Dis 60:527-30. 2001

Detail Information

Publications21

  1. ncbi request reprint Headache and systemic lupus erythematosus
    M J Cuadrado
    Lupus Research Unit, The Rayne Institute, St Thomas Hospital, London, UK
    Lupus 12:943-6. 2003
    ..Other concomitant causes such as infection or hypertension should be excluded before assuming that headache is a feature of SLE activity. Therapeutic approach of headache SLE-related remains empirical and based on clinical experience...
  2. doi request reprint Proteomics in antiphospholipid syndrome: a review
    M J Cuadrado
    Lupus Research Unit, St Thomas Hospital, London, UK
    Lupus 19:385-8. 2010
    ....
  3. ncbi request reprint Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS)
    Maria J Cuadrado
    Lupus Research Unit, Rayne Institute, St Thomas Hospital, London SE1 7EH, UK
    Rheumatology (Oxford) 53:275-84. 2014
    ....
  4. doi request reprint Is it time for biosimilars in autoimmune diseases?
    Maria Jose Cuadrado
    Louise Coote Lupus Unit, Guy s and St Thomas NHS Foundation Trust, St Thomas Hospital, London, UK
    Autoimmun Rev 12:954-7. 2013
    ..We aimed to review the crucial topics of efficacy, safety and regulatory approach of upcoming biosimilars. ..
  5. ncbi request reprint Thalidomide for the treatment of resistant cutaneous lupus: efficacy and safety of different therapeutic regimens
    Maria J Cuadrado
    Lupus Research Unit, The Rayne Institute, St Thomas Hospital, London, United Kingdom
    Am J Med 118:246-50. 2005
    ..Thalidomide is effective for the treatment of severe cutaneous lupus. Our aim was to study the safety and efficacy of different doses of thalidomide in this condition...
  6. ncbi request reprint Antiphospholipid syndrome
    M J Cuadrado
    Lupus Research Unit, The Rayne Institute, St Thomas Hospital, Lambeth Palace Road, SE1 7EH, London, UK
    Clin Exp Med 3:129-39. 2003
    ..Several prospective clinical trials are currently underway and their results will probably lead to a more precise therapeutic approach of this problem...
  7. ncbi request reprint Treatment and monitoring of patients with antiphospholipid antibodies and thrombotic history (Hughes syndrome)
    Maria J Cuadrado
    St Thomas Hospital, Lupus Research Unit, London SE1 7EH, United Kingdom
    Curr Rheumatol Rep 4:392-8. 2002
    ..The development of new therapies that target more specific pathogenic mechanisms is highly warranted...
  8. ncbi request reprint Hughes (antiphospholipid) syndrome. Clinical features
    M J Cuadrado
    Lupus Research Unit, Rayne Institute, St. Thomas' Hospital, London, United Kingdom
    Rheum Dis Clin North Am 27:507-24, v. 2001
    ..Recurrent thrombosis together with an adverse pregnancy history and the presence of antiphospholipid antibodies defines the syndrome...
  9. pmc Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis
    P Alba
    Lupus Research Unit, The Rayne Institute, UK
    Ann Rheum Dis 62:556-60. 2003
    ..Lupus nephritis (LN) is a common manifestation in patients with systemic lupus erythematosus (SLE). Autoantibodies and ethnicity have been associated with LN, but the results are controversial...
  10. pmc Characteristics of patients with antiphospholipid syndrome with major bleeding after oral anticoagulant treatment
    G Castellino
    Lupus Research Unit, The Rayne Institute, St Thomas's Hospital, London, UK
    Ann Rheum Dis 60:527-30. 2001
    ..CONCLUSION: No relation was established between age, duration of oral anticoagulant treatment, and bleeding. Concomitant drugs, mainly aspirin, and high blood pressure were present at the time of bleeding in a large number of patients...
  11. ncbi request reprint Mycophenolate mofetil treatment in resistant myositis
    C N Pisoni
    Lupus Research Unit, The Rayne Institute, King s College London School of Medicine at Guy s, King s and St Thomas Hospitals, St Thomas Hospital, London, UK
    Rheumatology (Oxford) 46:516-8. 2007
    ..To assess the efficacy and tolerability of mycophenolate mofetil (MMF) in six patients with myositis refractory to conventional immunosuppressive therapy...
  12. ncbi request reprint Vascular endothelial growth factor expression in monocytes from patients with primary antiphospholipid syndrome
    M J Cuadrado
    Lupus Research Unit, St Thomas Hospital, London, UK, and Research Unit and Rheumatology Department, Reina Sofia University Hospital, Cordoba, Spain
    J Thromb Haemost 4:2461-9. 2006
    ..Vascular endothelial growth factor (VEGF) may stimulate monocyte TF expression through its receptor, the tyrosine kinase Flt-1...
  13. ncbi request reprint Central nervous system involvement in the antiphospholipid (Hughes) syndrome
    G Sanna
    Lupus Research Unit, The Rayne Institute, St Thomas Hospital, London, UK
    Rheumatology (Oxford) 42:200-13. 2003
    ..In this review we focus on the common and some of the less common CNS manifestations that have been reported in association with antiphospholipid antibodies...
  14. ncbi request reprint Chromium-51 ethylenediamine tetraacetic acid glomerular filtration rate: a better predictor than glomerular filtration rate calculated by the Cockcroft-Gault formula for renal involvement in systemic lupus erythematosus patients
    T Godfrey
    Lupus Research Unit, The Rayne Institute, St Thomas' Hospital, London SE1 7EH, UK
    Rheumatology (Oxford) 40:324-8. 2001
    ..Significant numbers of patients with WHO class III, IV or V lupus nephritis may be missed if biochemical creatinine clearance or serum creatinine concentration alone is used to assess renal disease...
  15. ncbi request reprint Treatment of menorrhagia associated with oral anticoagulation: efficacy and safety of the levonorgestrel releasing intrauterine device (Mirena coil)
    C N Pisoni
    Lupus Research Unit, The Rayne Institute, King s College London School of Medicine at Guy s, King s and St Thomas Hospital, UK
    Lupus 15:877-80. 2006
    ..We feel the use of LNG-IUS is a major advance in reducing menorrhagia in women on oral anticoagulation as the previous alternative--hysterectomy--is associated with an increased risk of thrombosis and bleeding...
  16. ncbi request reprint Lack of association between antiphospholipid antibody and WHO classification in lupus nephritis
    C Fofi
    Lupus Research Unit, Rayne Institute, St Thomas' Hospital, London
    Clin Exp Rheumatol 19:75-7. 2001
    ..The presence of these antibodies does not seem to be related to histological activity or the chronicity of lupus nephritis nor proteinuria...
  17. ncbi request reprint Mycophenolate mofetil and systemic lupus erythematosus: an overview
    C N Pisoni
    St Thomas Hospital, London, UK
    Lupus 14:s9-11. 2005
    ..In this review, we discuss our own experience and the literature report about the use of MMF in SLE...
  18. ncbi request reprint Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus?
    José A Gómez-Puerta
    Lupus Research Unit, Rayne Institute, St Thomas Hospital, London, United Kingdom
    Medicine (Baltimore) 84:225-30. 2005
    ..Only 3 patients developed anti-dsDNA antibodies. The presence of a positive Coombs test might be a marker for the development of SLE in patients with primary APS...
  19. ncbi request reprint Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5
    Guillermo Ruiz-Irastorza
    Lupus Research Unit, The Rayne Institute, St Thomas Hospital, London SE1 7EH, England
    Arch Intern Med 162:1164-9. 2002
    ..Prolonged anticoagulation is the treatment of choice for patients with thrombosis and the antiphospholipid syndrome. However, there is still debate about the optimum intensity of anticoagulation...
  20. ncbi request reprint Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies
    Giovanni Sanna
    Lupus Research Unit, The Rayne Institute, London, UK
    J Rheumatol 30:985-92. 2003
    ..Neuropsychometric testing was applied by a neuropsychologist. Univariate and multivariate statistical analyses were applied to evaluate the association bewteen NP manifestations, magnetic resonance imaging (MRI) abnormalities, and aPL...
  21. ncbi request reprint Mycophenolate mofetil in systemic lupus erythematosus: efficacy and tolerability in 86 patients
    Cecilia N Pisoni
    Lupus Research Unit, The Rayne Institute, St Thomas Hospital, London, UK
    J Rheumatol 32:1047-52. 2005
    ..To assess the indications, efficacy, and tolerability of mycophenolate mofetil (MMF) in patients with systemic lupus erythematosus (SLE) resistant to other immunosuppressive therapy...